Wird geladen...
Molecular mechanism and potential target indication of TAK-931, a novel CDC7-selective inhibitor
Replication stress (RS) is a cancer hallmark; chemotherapeutic drugs targeting RS are widely used as treatments for various cancers. To develop next-generation RS-inducing anticancer drugs, cell division cycle 7 (CDC7) has recently attracted attention as a target. We have developed an oral CDC7-sele...
Gespeichert in:
| Veröffentlicht in: | Sci Adv |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Association for the Advancement of Science
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6531005/ https://ncbi.nlm.nih.gov/pubmed/31131319 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.aav3660 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|